{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:45:29Z","timestamp":1790394329274,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Aier Eye-Sichuan University Research Fundation","award":["23JZH046"],"award-info":[{"award-number":["23JZH046"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17122-x","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:03:34Z","timestamp":1758884614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigating the role of the ALPK1 signaling pathway in the pathogenesis of diabetic retinopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Ting","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Kun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yi","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Shang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Rong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Hong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"17122_CR1","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","volume":"376","author":"N Cheung","year":"2010","unstructured":"Cheung, N., Mitchell, P. & Wong, T. Y. Diabetic retinopathy. Lancet 376, 124\u2013136 (2010).","journal-title":"Lancet"},{"key":"17122_CR2","doi-asserted-by":"publisher","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","volume":"5","author":"SR Flaxman","year":"2017","unstructured":"Flaxman, S. R. et al. Global causes of blindness and distance vision impairment 1990\u20132020: A systematic review and meta-analysis. Lancet Glob. Health 5, e1221\u2013e1234 (2017).","journal-title":"Lancet Glob. Health"},{"key":"17122_CR3","doi-asserted-by":"publisher","first-page":"e93751","DOI":"10.1172\/jci.insight.93751","volume":"2","author":"EJ Duh","year":"2017","unstructured":"Duh, E. J., Sun, J. K. & Stitt, A. W. Diabetic retinopathy: Current understanding, mechanisms, and treatment strategies. JCI Insight 2, e93751 (2017).","journal-title":"JCI Insight"},{"key":"17122_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.visres.2017.04.003","volume":"139","author":"J Lechner","year":"2017","unstructured":"Lechner, J., O\u2019Leary, O. E. & Stitt, A. W. The pathology associated with diabetic retinopathy. Vision Res. 139, 7\u201314 (2017).","journal-title":"Vision Res."},{"key":"17122_CR5","first-page":"75","volume":"107","author":"AN Kollias","year":"2010","unstructured":"Kollias, A. N. & Ulbig, M. W. Diabetic retinopathy: Early diagnosis and effective treatment. Dtsch Arztebl. Int. 107, 75\u201383 (2010).","journal-title":"Dtsch Arztebl. Int."},{"key":"17122_CR6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/jamaophthalmol.2015.4599","volume":"134","author":"JA Wells","year":"2016","unstructured":"Wells, J. A. et al. Association of baseline visual acuity and retinal thickness with 1-year efficacy of Aflibercept, Bevacizumab, and ranibizumab for diabetic macular edema. JAMA Ophthalmol. 134, 127\u2013134 (2016).","journal-title":"JAMA Ophthalmol."},{"key":"17122_CR7","doi-asserted-by":"publisher","first-page":"583687","DOI":"10.3389\/fimmu.2020.583687","volume":"11","author":"JV Forrester","year":"2020","unstructured":"Forrester, J. V., Kuffova, L. & Delibegovic, M. The role of inflammation in diabetic retinopathy. Front. Immunol. 11, 583687 (2020).","journal-title":"Front. Immunol."},{"key":"17122_CR8","doi-asserted-by":"publisher","first-page":"1055087","DOI":"10.3389\/fimmu.2022.1055087","volume":"13","author":"T Yue","year":"2022","unstructured":"Yue, T. et al. The role of inflammation in immune system of diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications. Front. Immunol. 13, 1055087 (2022).","journal-title":"Front. Immunol."},{"key":"17122_CR9","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1016\/S0960-9822(99)80006-2","volume":"9","author":"AG Ryazanov","year":"1999","unstructured":"Ryazanov, A. G., Pavur, K. S. & Dorovkov, M. V. Alpha-kinases: A new class of protein kinases with a novel catalytic domain. Curr. Biol. 9, R43-45 (1999).","journal-title":"Curr. Biol."},{"key":"17122_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jsbmb.2015.08.007","volume":"154","author":"T-M Kuo","year":"2015","unstructured":"Kuo, T.-M. et al. ALPK1 affects testosterone mediated regulation of proinflammatory cytokines production. J. Steroid Biochem. Mol. Biol. 154, 150\u2013158 (2015).","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"17122_CR11","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1038\/s41598-023-33459-7","volume":"13","author":"D Garc\u00eda-Weber","year":"2023","unstructured":"Garc\u00eda-Weber, D. et al. In vitro kinase assay reveals ADP-heptose-dependent ALPK1 autophosphorylation and altered kinase activity of disease-associated ALPK1 mutants. Sci. Rep. 13, 6278 (2023).","journal-title":"Sci. Rep."},{"key":"17122_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-018-0433-3","volume":"561","author":"P Zhou","year":"2018","unstructured":"Zhou, P. et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature 561, 122\u2013126 (2018).","journal-title":"Nature"},{"key":"17122_CR13","doi-asserted-by":"publisher","first-page":"109330","DOI":"10.1016\/j.intimp.2022.109330","volume":"113","author":"J-Y Li","year":"2022","unstructured":"Li, J.-Y. et al. Neuroprotective effect of alpha-kinase 1 knockdown against cerebral ischemia through inhibition of the NF-\u03baB pathway and neuroinflammation. Int. Immunopharmacol. 113, 109330 (2022).","journal-title":"Int. Immunopharmacol."},{"key":"17122_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40659-023-00416-7","volume":"56","author":"X Cui","year":"2023","unstructured":"Cui, X. et al. Alpha-kinase1 promotes tubular injury and interstitial inflammation in diabetic nephropathy by canonical pyroptosis pathway. Biol. Res. 56, 5 (2023).","journal-title":"Biol. Res."},{"key":"17122_CR15","doi-asserted-by":"publisher","first-page":"705751","DOI":"10.3389\/fimmu.2021.705751","volume":"12","author":"F Ding","year":"2021","unstructured":"Ding, F. et al. Alpk1 sensitizes pancreatic beta cells to cytokine-induced apoptosis via upregulating TNF-\u03b1 signaling pathway. Front. Immunol. 12, 705751 (2021).","journal-title":"Front. Immunol."},{"key":"17122_CR16","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41436-019-0476-3","volume":"21","author":"LB Williams","year":"2019","unstructured":"Williams, L. B. et al. ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. Genet. Med. 21, 2103\u20132115 (2019).","journal-title":"Genet. Med."},{"key":"17122_CR17","doi-asserted-by":"publisher","first-page":"e2313148120","DOI":"10.1073\/pnas.2313148120","volume":"120","author":"T Snelling","year":"2023","unstructured":"Snelling, T., Saalfrank, A., Wood, N. T. & Cohen, P. ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars. Proc. Natl. Acad. Sci. U. S. A. 120, e2313148120 (2023).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"17122_CR18","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/annrheumdis-2022-222629","volume":"81","author":"CT Kozycki","year":"2022","unstructured":"Kozycki, C. T. et al. Gain-of-function mutations in ALPK1 cause an NF-\u03baB-mediated autoinflammatory disease: Functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. Ann. Rheum. Dis. 81, 1453\u20131464 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"17122_CR19","doi-asserted-by":"publisher","first-page":"E254","DOI":"10.1152\/ajpendo.00353.2021","volume":"323","author":"M De Paoli","year":"2022","unstructured":"De Paoli, M. et al. Investigating the protective effects of estrogen on \u03b2-cell health and the progression of hyperglycemia-induced atherosclerosis. Am. J. Physiol. Endocrinol. Metab. 323, E254\u2013E266 (2022).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"17122_CR20","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/jcmm.17179","volume":"26","author":"M Jiang","year":"2022","unstructured":"Jiang, M. et al. Enhancing fractalkine\/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy. J. Cell. Mol. Med. 26, 1229\u20131244 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"17122_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cbi.2019.01.020","volume":"302","author":"K-C Chang","year":"2019","unstructured":"Chang, K.-C., Shieh, B. & Petrash, J. M. Role of aldose reductase in diabetes-induced retinal microglia activation. Chem. Biol. Interact. 302, 46\u201352 (2019).","journal-title":"Chem. Biol. Interact."},{"key":"17122_CR22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.4103\/1673-5374.355743","volume":"18","author":"L Tang","year":"2023","unstructured":"Tang, L., Xu, G.-T. & Zhang, J.-F. Inflammation in diabetic retinopathy: Possible roles in pathogenesis and potential implications for therapy. Neural Regen. Res. 18, 976\u2013982 (2023).","journal-title":"Neural Regen. Res."},{"key":"17122_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.visres.2017.04.013","volume":"139","author":"H Xu","year":"2017","unstructured":"Xu, H. & Chen, M. Diabetic retinopathy and dysregulated innate immunity. Vision Res. 139, 39\u201346 (2017).","journal-title":"Vision Res."},{"key":"17122_CR24","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/med.21711","volume":"40","author":"X Wang","year":"2020","unstructured":"Wang, X., Antony, V., Wang, Y., Wu, G. & Liang, G. Pattern recognition receptor-mediated inflammation in diabetic vascular complications. Med. Res. Rev. 40, 2466\u20132484 (2020).","journal-title":"Med. Res. Rev."},{"key":"17122_CR25","doi-asserted-by":"publisher","first-page":"1151185","DOI":"10.3389\/fimmu.2023.1151185","volume":"14","author":"X Zheng","year":"2023","unstructured":"Zheng, X., Wan, J. & Tan, G. The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy. Front. Immunol. 14, 1151185 (2023).","journal-title":"Front. Immunol."},{"key":"17122_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ije\/dyt028","volume":"42","author":"AM-S Ko","year":"2013","unstructured":"Ko, A.M.-S. et al. ALPK1 genetic regulation and risk in relation to gout. Int. J. Epidemiol. 42, 466\u2013474 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"17122_CR27","doi-asserted-by":"publisher","first-page":"e1009787","DOI":"10.1371\/journal.ppat.1009787","volume":"17","author":"J Cui","year":"2021","unstructured":"Cui, J. et al. The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells. PLoS Pathog. 17, e1009787 (2021).","journal-title":"PLoS Pathog."},{"key":"17122_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-020-03577-w","volume":"78","author":"D Garc\u00eda-Weber","year":"2021","unstructured":"Garc\u00eda-Weber, D. & Arrieumerlou, C. ADP-heptose: A bacterial PAMP detected by the host sensor ALPK1. Cell. Mol. Life Sci. 78, 17\u201329 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"17122_CR29","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/jbmr.4669","volume":"37","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. ALPK1 accelerates the pathogenesis of osteoarthritis by activating NLRP3 signaling. J. Bone Miner. Res. 37, 1973\u20131985 (2022).","journal-title":"J. Bone Miner. Res."},{"key":"17122_CR30","doi-asserted-by":"publisher","first-page":"174166","DOI":"10.1016\/j.ejphar.2021.174166","volume":"904","author":"A Al Mamun","year":"2021","unstructured":"Al Mamun, A. et al. Role of pyroptosis in diabetic retinopathy and its therapeutic implications. Eur. J. Pharmacol. 904, 174166 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"17122_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1076\/ocii.10.1.27.10328","volume":"10","author":"L Chen","year":"2002","unstructured":"Chen, L., Yang, P. & Kijlstra, A. Distribution, markers, and functions of retinal microglia. Ocul. Immunol. Inflamm. 10, 27\u201339 (2002).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"17122_CR32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1189\/jlb.0207114","volume":"81","author":"T Langmann","year":"2007","unstructured":"Langmann, T. Microglia activation in retinal degeneration. J. Leukoc. Biol. 81, 1345\u20131351 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"17122_CR33","doi-asserted-by":"publisher","first-page":"564077","DOI":"10.3389\/fimmu.2020.564077","volume":"11","author":"UM Kinuthia","year":"2020","unstructured":"Kinuthia, U. M., Wolf, A. & Langmann, T. Microglia and inflammatory responses in diabetic retinopathy. Front. Immunol. 11, 564077 (2020).","journal-title":"Front. Immunol."},{"key":"17122_CR34","doi-asserted-by":"publisher","first-page":"E006","DOI":"10.1017\/S0952523821000031","volume":"38","author":"X Li","year":"2021","unstructured":"Li, X. et al. Retinal microglia polarization in diabetic retinopathy. Vis. Neurosci. 38, E006 (2021).","journal-title":"Vis. Neurosci."},{"key":"17122_CR35","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","volume":"113","author":"EH Sohn","year":"2016","unstructured":"Sohn, E. H. et al. Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus. Proc. Natl. Acad. Sci. U. S. A. 113, E2655-2664 (2016).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"17122_CR36","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1365-2567.2011.03514.x","volume":"135","author":"AL Cardoso","year":"2012","unstructured":"Cardoso, A. L., Guedes, J. R., Pereira de Almeida, L. & Pedroso de Lima, M. C. miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production. Immunology 135, 73\u201388 (2012).","journal-title":"Immunology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17122-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17122-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17122-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:03:35Z","timestamp":1758884615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17122-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17122"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17122-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"26 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33103"}}